menu
    • menu

    Company profile for BioLineRx

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BioLineRx is a clinical-stage biopharmaceutical company focused on oncology. The Company in-licenses novel compounds, develops them through pre-clinical and/or clinical stages, and then partners with pharmaceutical companies for advanced clinical development and/or commercialization. BioLineRx’s leading therapeutic candidates are: BL-8040, a cancer therapy platform, which has successfully completed a Phase 2a study for relap...
    BioLineRx is a clinical-stage biopharmaceutical company focused on oncology. The Company in-licenses novel compounds, develops them through pre-clinical and/or clinical stages, and then partners with pharmaceutical companies for advanced clinical development and/or commercialization. BioLineRx’s leading therapeutic candidates are: BL-8040, a cancer therapy platform, which has successfully completed a Phase 2a study for relapsed/refractory AML, is in the midst of a Phase 2b study as an AML consolidation treatment and has initiated a Phase 3 study in stem cell mobilization for autologous transplantation.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BioLineRxIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    Modi’in Technology Park 2 HaMa’ayan Street Modi’in 7177871
    Telephone
    Telephone
    +972-8-642-9100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.biolinerx.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/biolinerx
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/biolinerx_ltd?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biolinerx Unveils Q3 2025 Financials And Corporate Update
    Biolinerx Unveils Q3 2025 Financials And Corporate Update

    24 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biolinerx-reports-third-quarter-2025-financial-results-and-provides-corporate-update-302624413.html

    PR NEWSWIRE
    24 Nov 2025
    Share Share
    Hemispherian Secures GLIX1 Patent for Solid Tumors
    Hemispherian Secures GLIX1 Patent for Solid Tumors

    19 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251119133483/en/Hemispherian-Announces-USPTO-Notice-of-Allowance-for-Key-GLIX1-Patent-Covering-Majority-of-Solid-Tumors

    BUSINESSWIRE
    19 Nov 2025
    Share Share
    Biolinerx To Release Q3 2025 Results On Nov 24, 2025
    Biolinerx To Release Q3 2025 Results On Nov 24, 2025

    18 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biolinerx-to-report-third-quarter-2025-results-on-november-24-2025-302618423.html

    PR NEWSWIRE
    18 Nov 2025
    Share Share
    Biolinerx Receives USPTO Notice For GLIX1 Cancer Treatment
    Biolinerx Receives USPTO Notice For GLIX1 Cancer Treatment

    17 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biolinerx-announces-receipt-of-uspto-notice-of-allowance-for-key-patent-covering-glix1-for-treating-a-broad-range-of-cancer-types-302616834.html

    PR NEWSWIRE
    17 Nov 2025
    Share Share
    Biolinerx, Hemispherian As Form Joint Venture For Glix1
    Biolinerx, Hemispherian As Form Joint Venture For Glix1

    29 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biolinerx-ltd-and-hemispherian-as-establish-joint-venture-to-develop-glix1-a-first-in-class-oral-small-molecule-targeting-dna-damage-response-in-glioblastoma-and-other-cancers-302569321.html

    PR NEWSWIRE
    29 Sep 2025
    Share Share
    BioLine Rx Reports Q2 2025 Financials, Updates on Corporate
    BioLine Rx Reports Q2 2025 Financials, Updates on Corporate

    14 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biolinerx-reports-second-quarter-2025-financial-results-and-provides-corporate-update-302530015.html

    PR NEWSWIRE
    14 Aug 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search